{"nctId":"NCT00003830","briefTitle":"Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer","startDateStruct":{"date":"1999-05"},"conditions":["Breast Cancer"],"count":5611,"armGroups":[{"label":"Arm I: Conventional axillary dissection","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: conventional surgery"]},{"label":"Arm II: Sentinel node resection followed by node examination","type":"EXPERIMENTAL","interventionNames":["Procedure: Sentinel node resection followed by node examination"]}],"interventions":[{"name":"conventional surgery","otherNames":[]},{"name":"Sentinel node resection followed by node examination","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"DISEASE CHARACTERISTICS:\n\n* Resectable invasive adenocarcinoma of the breast, confirmed by 1 of the following:\n\n  * Histologically confirmed by core or open biopsy\n  * Confirmed by fine needle aspiration cytology AND positive clinical breast examination and ultrasound or mammography\n* Clinically negative lymph nodes\n\n  * No positive ipsilateral axillary lymph nodes\n  * No prior removal of ipsilateral axillary lymph nodes\n  * No suspicious palpable nodes in the contralateral axilla or palpable supraclavicular or infraclavicular nodes, unless proven nonmalignant by biopsy\n* No ulceration, erythema, infiltration of the skin or underlying chest wall (complete fixation), peau d'orange, or skin edema of any magnitude\n\n  * Tethering or dimpling of the skin or nipple inversion allowed\n* No bilateral malignancy or mass in the opposite breast that is suspicious for malignancy, unless proven nonmalignant by biopsy\n* No diffuse tumors or multiple malignant tumors in different quadrants of the breast\n* No other prior breast malignancy except lobular carcinoma in situ\n* No prior or concurrent breast implants\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 18 years and older\n\nSex:\n\n* Female\n\nMenopausal status:\n\n* Not specified\n\nPerformance status:\n\n* Not specified\n\nLife expectancy:\n\n* At least 10 years (excluding diagnosis of cancer)\n\nHematopoietic:\n\n* Not specified\n\nHepatic:\n\n* No hepatic systemic disease\n\nRenal:\n\n* No renal systemic disease\n\nCardiovascular:\n\n* No cardiovascular systemic disease\n\nOther:\n\n* No prior malignancy within past 5 years except:\n\n  * Effectively treated squamous cell or basal cell skin cancer\n  * Surgically treated carcinoma in situ of the cervix\n  * Surgically treated lobular carcinoma in situ of the ipsilateral or contralateral breast\n* No concurrent psychiatric or addictive disorder\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy:\n\n* No prior immunotherapy for this cancer\n\nChemotherapy:\n\n* No prior chemotherapy for this cancer, including neoadjuvant chemotherapy\n\nEndocrine therapy:\n\n* No prior hormonal therapy for this cancer\n\nRadiotherapy:\n\n* No prior radiotherapy for this cancer\n\nSurgery:\n\n* See Disease Characteristics\n* No prior breast reduction surgery\n* Prior excisional biopsy or lumpectomy allowed","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Morbidity - Number of Participants With Residual Shoulder Abduction Deficit","description":"Morbidity as measured by residual shoulder abduction deficit. Shoulder Abduction Deficit definition: Shoulder range of motion decreased by greater than or equal to 10% as compared with that measured prior to surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"276","spread":null},{"groupId":"OG001","value":"200","spread":null}]}]}]},{"type":"PRIMARY","title":"Morbidity - Number of Participants With Residual Arm Volume Difference","description":"Morbidity as measured by residual arm volume difference. Residual Arm Volume Difference definition: Arm volume differences greater than or equal to 10% as compared with that measured prior to surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"314","spread":null},{"groupId":"OG001","value":"192","spread":null}]}]}]},{"type":"PRIMARY","title":"Morbidity - Number of Participants With Residual Arm Numbness","description":"Morbidity as measured by residual arm numbness","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"408","spread":null},{"groupId":"OG001","value":"103","spread":null}]}]}]},{"type":"PRIMARY","title":"Morbidity - Number of Participants With Residual Arm Tingling","description":"Morbidity as measured by residual arm tingling","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"175","spread":null},{"groupId":"OG001","value":"90","spread":null}]}]}]},{"type":"PRIMARY","title":"Overall Survival","description":"Measured at the time from randomization to any death to determine the percentage of patients alive at 8 years","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"91.8","spread":null},{"groupId":"OG001","value":"90.3","spread":null}]}]}]},{"type":"PRIMARY","title":"Disease-free Survival as Measured by Breast Cancer Recurrence, Any Second Primary Cancer, and Death From Any Cause in Patients Without a Prior Event.","description":"Measured at time from randomization to recurrence, second primary, or death to determine the percentage of patients disease free at 8 years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82.4","spread":null},{"groupId":"OG001","value":"81.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence","description":"Percentage of patients distant disease-free at 5 years. Sentinel node definition: Sentinel nodes are the first few lymph nodes into which a tumor drains. Sentinel node biopsy requires injecting a tracer material to help a surgeon locate sentinel nodes during surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92.5","spread":null},{"groupId":"OG001","value":"89.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence","description":"Measured at time from randomization to any distant cancer or death to determine percentage of patients distant disease free at 5 years. Sentinel node definition: Sentinel nodes are the first few lymph nodes into which a tumor drains. Sentinel node biopsy requires injecting a tracer material to help a surgeon locate sentinel nodes during surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92.5","spread":null},{"groupId":"OG001","value":"89.7","spread":null}]}]}]},{"type":"SECONDARY","title":"The Percentage of Technically Successful Sentinel Node Resections as Measured by the Proportion of Patients for Whom at Least One Sentinel Node is Identified.","description":"Sentinel node definition: Sentinel nodes are the first few lymph nodes into which a tumor drains. Sentinel node biopsy requires injecting a tracer material to help a surgeon locate sentinel nodes during surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2672","spread":null},{"groupId":"OG001","value":"2707","spread":null}]},{"measurements":[{"groupId":"OG000","value":"74","spread":null},{"groupId":"OG001","value":"83","spread":null}]}]}]},{"type":"SECONDARY","title":"Sensitivity of the Sentinel Node to Determine Presence of Nodal Metastases.","description":"Sentinel node definition: Sentinel nodes are the first few lymph nodes into which a tumor drains. Sentinel node biopsy requires injecting a tracer material to help a surgeon locate sentinel nodes during surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null}]},{"measurements":[{"groupId":"OG000","value":"691","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":2788},"commonTop":[]}}}